|
Market Closed -
Euronext Paris
19:55:00 18/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 6.480 EUR | +1.89% |
|
-12.43% | +3.68% |
| Market Cap | 36.5M 41.86M 34.46M 31.3M 58.63M 4.02B 58.88M 413M 159M 2.04B 157M 154M 6.57B | P/E 2026 * |
-16.6x | P/E 2027 * | 162x |
|---|---|---|---|---|---|
| Enterprise Value | 35M 40.14M 33.05M 30.01M 56.22M 3.85B 56.46M 396M 153M 1.96B 151M 147M 6.3B | EV / Sales 2026 * |
3.18x | EV / Sales 2027 * | 2.22x |
| Free-Float |
14.95% | Yield 2026 * |
-
| Yield 2027 * | - |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| ALSMA | Real-time | |
Börse Stuttgart
| G3O | Delayed | |
Deutsche Boerse AG
| G3O | Delayed |
| 1 day | +1.89% | ||
| 1 week | -12.43% | ||
| Current month | -14.06% | ||
| 1 month | -14.74% | ||
| 3 months | -17.77% | ||
| 6 months | -8.73% | ||
| Current year | +3.68% |
| 1 week | 6.16 | 7.4 | |
| 1 month | 6.16 | 7.76 | |
| Current year | 6 | 9.1 | |
| 1 year | 5.9 | 9.1 | |
| 3 years | 2.25 | 9.1 | |
| 5 years | 1.9 | 9.1 | |
| 10 years | 1.9 | 9.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/12/2008 | |
Renaut Fritsch
DFI | Director of Finance/CFO | - | 01/06/2022 |
Thibaut Bastien
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.89% | -12.43% | -1.07% | +157.14% | 41.86M | ||
| +0.04% | +3.34% | +53.32% | +102.40% | 1,028B | ||
| -0.09% | +1.66% | +53.24% | +65.73% | 651B | ||
| -0.02% | +2.66% | +18.65% | +71.84% | 466B | ||
| -1.22% | +3.66% | +34.59% | +39.32% | 346B | ||
| -0.79% | +2.73% | +17.73% | +23.91% | 266B | ||
| +0.58% | +6.76% | +10.58% | +14.16% | 259B | ||
| +1.55% | +2.20% | +35.12% | +42.07% | 208B | ||
| +0.79% | +1.84% | -27.55% | -57.51% | 191B | ||
| -0.52% | +4.45% | +31.57% | +97.98% | 186B | ||
| Average | +0.22% | +1.69% | +22.62% | +55.70% | 360.18B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.41% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 11M 12.61M 10.39M 9.43M 17.67M 1.21B 17.75M 124M 48.01M 615M 47.39M 46.33M 1.98B | 16M 18.35M 15.11M 13.72M 25.7M 1.76B 25.81M 181M 69.83M 895M 68.93M 67.4M 2.88B |
| Net income | -2.25M -2.58M -2.12M -1.93M -3.61M -248M -3.63M -25.45M -9.82M -126M -9.69M -9.48M -405M | 250K 287K 236K 214K 402K 27.51M 403K 2.83M 1.09M 13.99M 1.08M 1.05M 45M |
| Net Debt | -1.5M -1.72M -1.42M -1.29M -2.41M -165M -2.42M -16.97M -6.55M -83.92M -6.46M -6.32M -270M | -900K -1.03M -850K -772K -1.45M -99.04M -1.45M -10.18M -3.93M -50.35M -3.88M -3.79M -162M |
Employees
45
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | €6.480 | +1.89% | 1,236 |
| 17/09/26 | €6.360 | -4.50% | 1,100 |
| 16/09/26 | €6.660 | -2.92% | 825 |
| 15/09/26 | €6.860 | -8.53% | 888 |
| 14/09/26 | €7.500 | +1.35% | 21 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.480EUR
Average target price
8.200EUR
Spread / Average Target
+26.54%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALSMA Stock
Select your edition
All financial news and data tailored to specific country editions

















